IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PATIENTS WITH VASCULITIS RECEIVING STANDARD OF CARE THERAPY AND CONTROLS

被引：0
|
作者：
Nived, P. [1 ]
Nagel, J. [1 ]
Saxne, T. [1 ]
Geborek, P. [1 ]
Jonsson, G. [1 ]
Skattum, L. [1 ]
Kapetanovic, M. C. [1 ]
机构：
[1] Lund Univ, Lund, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0386
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [21] Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine
    Ceyhan, Mehmet
    JOURNAL OF PEDIATRIC INFECTION, 2011, 5 (02): : 68 - 73
  • [22] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
  • [23] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
    Chilson, Erica
    Scott, Daniel A.
    Schmoele-Thoma, Beate
    Watson, Wendy
    Moran, Mary M.
    Isturiz, Raul
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (11) : 2758 - 2772
  • [24] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
    Shiramoto, Masanari
    Hanada, Ryuzo
    Juergens, Christine
    Shoji, Yasuko
    Yoshida, Mizuki
    Ballan, Barry
    Cooper, David
    Gruber, William C.
    Scott, Daniel A.
    Schmoele-Thoma, Beate
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (09) : 2198 - 2206
  • [25] Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Given With DTaP Vaccine in Healthy Infants in Japan
    Togashi, Takehiro
    Okada, Kenji
    Yamaji, Masako
    Thompson, Allison
    Gurtman, Alejandra
    Cutler, Mark
    Aizawa, Masakazu
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (10) : 1096 - 1104
  • [26] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +
  • [27] 13-Valent pneumococcal conjugate vaccine utilization in the primary care setting.
    Lomberk, Mary
    Rattray, Deanna
    Bean, Rebecca
    PHARMACOTHERAPY, 2016, 36 (07): : E110 - E110
  • [28] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
    Bhorat, As'ad E.
    Madhi, Shabir A.
    Laudat, France
    Sundaraiyer, Vani
    Gurtman, Alejandra
    Jansen, Kathrin U.
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    AIDS, 2015, 29 (11) : 1345 - 1354
  • [29] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
    Huang, Li-Min
    Lin, Tzou-Yien
    Juergens, Christine
    VACCINE, 2012, 30 (12) : 2054 - 2059
  • [30] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
    Duggan, Sean T.
    DRUGS, 2010, 70 (15) : 1973 - 1986
12345